U.S. markets closed

Viveve Medical, Inc. (VIVE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.4100+0.0100 (+0.42%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/13/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
25.96M10.18M8.22M8.80M6.91M
Enterprise Value 3
25.43M6.90M5.57M4.14M-2.15M
Trailing P/E
N/A0.020.08N/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
0.721.050.790.390.13
Price/Book (mrq)
3.720.921.060.710.42
Enterprise Value/Revenue 3
4.643.543.655.88-1.65
Enterprise Value/EBITDA 7
-1.32-1.67-1.78-0.640.38

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-59.15%
S&P500 52-Week Change 341.30%
52 Week High 314.4000
52 Week Low 32.4000
50-Day Moving Average 32.9015
200-Day Moving Average 33.8981

Share Statistics

Avg Vol (3 month) 3681.08k
Avg Vol (10 day) 3213.11k
Shares Outstanding 510.34M
Implied Shares Outstanding 6N/A
Float 9.9M
% Held by Insiders 10.00%
% Held by Institutions 115.52%
Shares Short (Apr 29, 2021) 41.08M
Short Ratio (Apr 29, 2021) 43.53
Short % of Float (Apr 29, 2021) 410.45%
Short % of Shares Outstanding (Apr 29, 2021) 410.45%
Shares Short (prior month Mar 30, 2021) 41.89M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 01, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Dec 01, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-316.39%

Management Effectiveness

Return on Assets (ttm)-37.64%
Return on Equity (ttm)-105.36%

Income Statement

Revenue (ttm)5.62M
Revenue Per Share (ttm)1.60
Quarterly Revenue Growth (yoy)11.20%
Gross Profit (ttm)296k
EBITDA -16.5M
Net Income Avi to Common (ttm)-25.68M
Diluted EPS (ttm)-7.3170
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)28.45M
Total Cash Per Share (mrq)2.69
Total Debt (mrq)6M
Total Debt/Equity (mrq)21.80
Current Ratio (mrq)7.92
Book Value Per Share (mrq)2.66

Cash Flow Statement

Operating Cash Flow (ttm)-12.75M
Levered Free Cash Flow (ttm)-7.23M